DIVA Laboratories, Ltd. (TPEX:4153)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical and Industrial Display Division	868.84M	862.32M	893.84M	949.20M	712.23M
Medical and Industrial Display Division Growth	0.76%	-3.53%	-5.83%	33.27%	-3.35%
Total	868.84M	862.32M	893.84M	949.20M	712.23M
Total Growth	0.76%	-3.53%	-5.83%	33.27%	-3.35%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	864.05M	860.96M	889.12M	991.50M	782.86M
Taiwan Growth	0.36%	-3.17%	-10.33%	26.65%	-6.36%
Overseas	21.43M	18.95M	22.57M	26.07M	14.47M
Overseas Growth	13.10%	-16.08%	-13.39%	80.18%	132.39%
Internal Write-Off	-16.64M	-17.59M	-17.85M	-68.37M	-85.09M
Total	868.84M	862.32M	893.84M	949.20M	712.23M
Total Growth	0.76%	-3.53%	-5.83%	33.27%	-3.35%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 25, 2026

Data Sources Report a data error